Updated Details,can be used as a potential alternative to antibiotic growth promoters

The quest for effective and safe alternatives to traditional antibiotics in livestock farming has led to a growing interest in antimicrobial peptides from pigs. These naturally occurring molecules, also known as host defence peptides (HDPs), are a crucial component of the innate immune response in pigs, just as they are in many other mammals. Research indicates that pigs, like many other mammals, produce an impressive array of AMPs, synthesized predominantly by host leukocytic phagocytes or mucosal epithelial cells. This inherent ability of swine to produce these potent compounds presents a significant opportunity for enhancing animal health and productivity.

Porcine antimicrobial peptides are a diverse group, with the cathelicidin family being particularly noteworthy. This family includes four main categories: PR-39, PG1-5 (protegrin), PF1-2 (prophenin), and others. Notably, porcine neutrophils are abundant in proline–phenylalanine-rich prophenin-1 (PF-1), highlighting a specific type of antibacterial peptides produced by these immune cells. Beyond neutrophils, porcine intestinal antimicrobial peptide (PIAP) has also emerged as a focus of research, investigated for its potential as an alternative to in-feed antibiotics. Porcine blood, a significant byproduct of the pork industry, is also being explored as a source of antimicrobial peptides through hydrolysis.

The application of antimicrobial peptides in swine production is multifaceted, with significant implications for animal welfare and economic efficiency. Studies consistently demonstrate that antimicrobial peptides could improve the growth performance and health condition of piglets and help fight infection. Specifically, research has shown that AMPs can improve piglet growth performance, leading to better feed efficiency and overall development. The inclusion of antimicrobial peptides in feed has been linked to reduced incidence of diarrhea and lower mortality rates in pigs receiving these supplemented diets compared to those that are not. This suggests that antimicrobial peptides can promote the performance of pigs by bolstering their resilience against common pathogens.

Beyond growth promotion, antimicrobial peptides play a vital role in strengthening the immune system and improving gut health. They enhance feed efficiency, promote growth, prevent infection, and strengthen intestinal barrier function, making them promising candidates for use in swine. The intestinal barrier is pivotal, especially during the weaning phase of piglets, as it absorbs and secretes specific substances, increases tolerance to foreign antigens, and is crucial for overall health. AMPs contribute to this by helping to neutralize endotoxin produced by gram-negative bacteria, a common challenge in animal husbandry.

The potential of antimicrobial peptides extends to their role as alternatives to antibiotic growth promoters. Antimicrobial peptide-A3 can be used as a potential alternative to antibiotic growth promoters in weanling pigs. Similarly, porcine intestinal antimicrobial peptide (PIAP) is being investigated for its efficiency as an alternative to in-feed antibiotics. This shift is crucial in the context of global health initiatives like the One Health framework, which emphasizes the interconnectedness of human, animal, and environmental health. Research exploring the application of AMPs in livestock farming aims to mitigate the impact of current practices within this framework.

Furthermore, antimicrobial peptides have demonstrated efficacy in combating various challenges faced in swine production, including viral infections. Reviews focusing on the application of antimicrobial peptides as growth and health promotors highlight their broader impact. Antimicrobial lactoferrin peptides are recognized as one of the most prevalent AMPs utilized in this regard. The mechanism of action of these peptides is diverse, often involving disruption of microbial cell membranes, but their capacity to combat viruses in swine production is also a significant area of ongoing investigation.

The administration and formulation of antimicrobial peptides are also areas of active research. For instance, the addition of immobilized antimicrobial peptides to swine diets has shown effectiveness in relieving weaning stress, evidenced by improved growth parameters. This suggests that even modified forms of these peptides can deliver significant benefits. Studies on the effects of immobilized antimicrobial peptides on growth indicate that specific dosages, such as 1,000 mg/kg, can effectively alleviate weaning stress. The form of administration in pigs is also being considered, with peptides capable of neutralizing endotoxins being a key area of focus.

In conclusion, antimicrobial peptides from pigs represent a promising and sustainable approach to improving animal health and performance in modern agriculture. Their natural origin, diverse mechanisms of action, and proven benefits in growth promotion, immune support, and pathogen control make them valuable tools for the swine industry. As research continues to uncover the full potential of these antimicrobial peptides, their role as alternatives to conventional antibiotics is likely to expand, contributing to healthier animals and a more responsible approach to food production.